The prevalence and fatality rates of cutaneous malignant melanoma (CMM) have been rising, particularly among the elderly.
Health Professionals
MMS-I Treatment Is Linked to Low Recurrence, Mortality in Head and Neck Melanoma
Mohs micrographic surgery with melanocytic immunostains (MMS-I) is emerging as an effective treatment option for invasive melanomas, particularly in anatomically constrained areas, due to a low risk of local recurrence and disease-specific mortality, according to study results published in Dermatologic Surgery.
Impact of Malignant Melanoma on Employment and Work Ability
The study underscores the importance of addressing work-related concerns for patients with melanoma, advocating for effective communication about rehabilitation options.
Tumor-Infiltrating Lymphocyte Therapy Tackles Treatment Blind Spot in Advanced Melanoma
Treatment options after progression on anti–PD-1 and BRAF/MEK inhibitors have been limited but TIL therapy has expanded metastatic melanoma treatment.